← Leaderboards

Paul Wender

University Of California Los Angeles

Google Scholar ↗PubMed ↗ORCID ↗

$20,449,594

Attributed

$25,605,078

Total exposure

14

Grants

8

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY2005–25

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$25,605,078 · 14

By mechanism

R01$19,092,362 · 5

R37$4,514,753 · 1

R56$1,595,652 · 2

P41$204,471 · 5

U54$197,840 · 1

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Jerome A. Zack$38,514,975
Caius Gabriel Radu$8,088,566

Others in their field

Top investigators on “Design”

Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
Sonia M Thomas · Research Triangle Institute$700,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
Jeffrey P Krischer · University Of South Florida$427,700,530
David R. Weir · University Of Michigan At Ann Arbor$385,316,144

Research focus

DesignCellsEvaluationAnalogPharmaceutical PreparationsPre-ClinicalProgramsProtein Kinase CBaseIn VitroStructureBryostatinMalignant NeoplasmsUptakeDrug Delivery SystemsClinical TrialsLeadCancer TherapyBiologicalResistanceFamilyNovel TherapeuticsTissuesToxic Effect

Grant awards (69)

Towards HIV eradication: New concepts and potent compounds for PKC-mediated latency reversal$721,067

R01 · FY2025 · AI

Synthetic Studies Related to Cancer Research/Treatment$430,697

R01 · FY2025 · CA · contact PI

Towards HIV eradication: New concepts and potent compounds for PKC-mediated latency reversal$751,879

R01 · FY2024 · AI

New Materials to Deliver mRNA: Applications in Cancer Immunotherapy$525,103

R01 · FY2024 · CA

Synthetic Studies Related to Cancer Research/Treatment$409,237

R01 · FY2024 · CA · contact PI

New Materials to Deliver mRNA: Applications in Cancer Immunotherapy$514,997

R01 · FY2023 · CA

Towards HIV eradication: New concepts and potent compounds for PKC-mediated latency reversal$469,113

R01 · FY2023 · AI

Synthetic Studies Related to Cancer Research/Treatment$430,815

R01 · FY2023 · CA · contact PI

Towards HIV eradication: New concepts and potent compounds for PKC-mediated latency reversal$797,798

R56 · FY2022 · AI

New Materials to Deliver mRNA: Applications in Cancer Immunotherapy$512,443

R01 · FY2022 · CA

Synthetic Studies Related to Cancer Research/Treatment$427,796

R01 · FY2022 · CA · contact PI

HIV Latency Reversal Through Novel, Potent PKC Modulators$797,854

R56 · FY2021 · AI

New Materials to Deliver mRNA: Applications in Cancer Immunotherapy$522,472

R01 · FY2021 · CA

HIV latency reversal through novel, potent PKC modulators$682,208

R01 · FY2020 · AI

New Materials to Deliver mRNA: Applications in Cancer Immunotherapy$546,613

R01 · FY2020 · CA

Synthetic Studies Related to Cancer Research/Treatment$426,570

R01 · FY2020 · CA · contact PI

HIV latency reversal through novel, potent PKC modulators$679,992

R01 · FY2019 · AI

Synthetic Studies Related to Cancer Research/Treatment$415,618

R01 · FY2019 · CA · contact PI

HIV latency reversal through novel, potent PKC modulators$641,213

R01 · FY2018 · AI

Synthetic Studies Related to Cancer Research/Treatment$430,458

R01 · FY2018 · CA · contact PI

HIV latency reversal through novel, potent PKC modulators$628,963

R01 · FY2017 · AI

Synthetic Studies Related to Cancer Research/Treatment$445,085

R01 · FY2017 · CA · contact PI

HIV latency reversal through novel, potent PKC modulators$645,378

R01 · FY2016 · AI

Synthetic Studies Related to Cancer Research/Treatment$451,239

R01 · FY2016 · CA · contact PI

Synthetic Studies Related to Cancer Research/Treatment$442,838

R37 · FY2015 · CA · contact PI

Synthetic Studies Related to Cancer Research/Treatment$430,552

R37 · FY2014 · CA · contact PI

Synthetic Studies on Tumor Promoters and Inhibitors$313,323

R01 · FY2014 · CA · contact PI

Synthetic Studies Related to Cancer Research/Treatment$420,573

R37 · FY2013 · CA · contact PI

Synthetic Studies on Tumor Promoters and Inhibitors$305,768

R01 · FY2013 · CA · contact PI

Chemistry of Probes and Therapeutics$171,936

U54 · FY2013 · CA · contact PI

Synthetic Studies Related to Cancer Research/Treatment$445,327

R37 · FY2012 · CA · contact PI

Synthetic Studies on Tumor Promoters and Inhibitors$327,560

R01 · FY2012 · CA · contact PI

Chemistry of Probes and Therapeutics$4,213

U54 · FY2012 · CA · contact PI

Synthetic Studies Related to Cancer Research/Treatment$423,345

R37 · FY2011 · CA · contact PI

Synthetic Studies on Tumor Promoters and Inhibitors$329,840

R01 · FY2011 · CA · contact PI

Chemistry of Probes and Therapeutics$5,817

U54 · FY2011 · CA · contact PI

Synthetic Studies Related to Cancer Research/Treatment$441,986

R37 · FY2010 · CA · contact PI

Synthetic Studies on Tumor Promoters and Inhibitors$328,087

R01 · FY2010 · CA · contact PI

Synthetic Studies Related to Cancer Research/Treatment$89,600

R37 · FY2010 · CA · contact PI

Chemistry of Probes and Therapeutics$6,150

U54 · FY2010 · CA · contact PI

Synthetic Studies Related to Cancer Research/Treatment$443,522

R37 · FY2009 · CA · contact PI

Synthetic Studies on Tumor Promoters and Inhibitors$322,699

R01 · FY2009 · CA · contact PI

Synthetic Studies Related to Cancer Research/Treatment$67,848

R37 · FY2009 · CA · contact PI

Chemistry of Probes and Therapeutics$6,355

U54 · FY2009 · CA · contact PI

SYNTHETIC STUDIES ON TUMOR PROMOTERS & INHIBITORS$718

P41 · FY2009 · RR · contact PI

Synthetic Studies Related to Cancer Research/Treatment$437,130

R37 · FY2008 · CA · contact PI

Synthetic Studies on Tumor Promoters and Inhibitors$315,720

R01 · FY2008 · CA · contact PI

SYNTHETIC STUDIES ON TUMOR PROMOTERS & INHIBITORS$3,587

P41 · FY2008 · RR · contact PI

Chemistry of Probes and Therapeutics$3,369

U54 · FY2008 · CA · contact PI

Synthetic Studies Related to Cancer Research/Treatment$435,815

R37 · FY2007 · CA · contact PI

Synthetic Studies on Tumor Promoters and Inhibitors$315,060

R01 · FY2007 · CA · contact PI

SYNTHETIC STUDIES ON TUMOR PROMOTERS & INHIBITORS$9,011

P41 · FY2007 · RR · contact PI

Synthetic Studies Related to Cancer Research/Treatment$436,217

R37 · FY2006 · CA · contact PI

Synthetic Studies on Tumor Promoters and Inhibitors$317,558

R01 · FY2006 · CA · contact PI

SYNTHETIC STUDIES ON TUMOR PROMOTERS & INHIBITORS: ANTI AIDS DRUG$66,957

P41 · FY2006 · RR · contact PI

Synthetic Studies Related to Cancer Research/Treatment$436,217

R01 · FY2005 · CA

Synthetic Studies on Tumor Promoters and Inhibitors$342,226

R01 · FY2005 · CA

SYNTHETIC STUDIES ON TUMOR PROMOTERS &INHIBITORS: ANTI AIDS DRUG$96,515

P41 · FY2005 · RR

Synthetic Studies Related to Cancer Research/Treatment$426,144

R01 · FY2004 · CA

SYNTHETIC STUDIES ON TUMOR PROMOTERS AND INHIBITORS$323,321

R01 · FY2004 · CA

SYNTHETIC STUDIES ON TUMOR PROMOTERS &INHIBITORS$27,683

P41 · FY2004 · RR

Synthetic Studies Related to Cancer Research/Treatment$416,369

R01 · FY2003 · CA

SYNTHETIC STUDIES ON TUMOR PROMOTERS AND INHIBITORS$316,550

R01 · FY2003 · CA

Synthetic Studies Related to Cancer Research/Treatment$406,876

R01 · FY2002 · CA

SYNTHETIC STUDIES ON TUMOR PROMOTERS AND INHIBITORS$309,977

R01 · FY2002 · CA

Synthetic Studies Related to Cancer Research/Treatment$417,165

R01 · FY2001 · CA

SYNTHETIC STUDIES ON TUMOR PROMOTERS AND INHIBITORS$303,592

R01 · FY2001 · CA

SYNTHETIC STUDIES RELATED TO CANCER RESEARCH/TREATMENT$493,306

R01 · FY2000 · CA

SYNTHETIC STUDIES ON TUMOR PROMOTERS AND INHIBITORS$316,048

R01 · FY2000 · CA